Upcoming Events
More events are coming soon.
Past Events
Dec 10 - Dec 13, 2022
|
|
Nov 8, 2022
|
|
Nov 4 - Nov 8, 2022
|
Abstract title: GB1211, an oral galectin-3 inhibitor, in decompensated cirrhotic patients: initial findings from the Phase 2 randomized, placebo-controlled GULLIVER-2 trial (late-breaking oral presentation) Poster title: GULLIVER-2 is an innovative, hybrid, hepatic impairment trial of the oral galectin-3 inhibitor GB1211 (poster presentation) Poster title: The novel galectin-3 inhibitor GB1211 reduces inflammation & fibrosis in a rabbit high fat diet model of NASH & fibrosis (late-breaking poster presentation) |
Jun 3 - Jun 7, 2022
|
|
May 13 - May 18, 2022
|
Poster title: DEFINE - a Randomized, Open-Label Trial of the Inhaled Galectin-3 Inhibitor GB0139 in Hospitalized Patients with Moderate-to-Severe COVID-19 |